HHCepo 100mg Dry Syrup contains Cefpodoxime Proxetil equivalent to 100mg per 5ml, a third-generation cephalosporin antibiotic with broad-spectrum activity against various gram-positive and gram-negative bacteria. It is indicated for the treatment of bacterial infections including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and otitis media. Cefpodoxime Proxetil acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The dry syrup formulation is designed for pediatric use, providing an accurate and palatable dosing option. Prior to administration, the dry powder should be reconstituted with the specified amount of water to achieve the desired concentration. Dosage and duration of therapy should be determined based on the severity of infection, patient age, and renal function. It is contraindicated in patients with known hypersensitivity to cephalosporins or penicillins. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain. Caution is advised in patients with a history of hypersensitivity reactions or renal impairment. As with all antibiotics, it is essential to complete the prescribed course to prevent resistance development. Consultation with a healthcare professional is recommended before initiating therapy.